Add to comparison table
Insider Transactions
5Y price score: (39) 
5Y return: -28.97%
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
DATE RANGE:
USD PER SHARE
- Stock price
- Sales
- Purchases
- Stock awards
Transaction History
Trade log
| Date | Action | Shares | Price | Share Value | Holding | Name | Title | Source |
|---|---|---|---|---|---|---|---|---|
| 16-sep.-26 | Sale | (1,483) | 93.7 | (138,883) | 42,186 | KIIL HARRY SKIP | officer: EVP & President Cardiovascular | link |
| 03-aug.-26 | Award | 2,337 | - | - | 16,998 | Blomquist Denise L. | officer: Chief Accounting Officer | link |
| 03-aug.-26 | Award | 2,337 | - | - | 2,337 | Blomquist Denise L. | officer: Chief Accounting Officer | link |
| 03-aug.-26 | Award | 1,366 | 86.7 | 118,405 | 1,366 | Blomquist Denise L. | officer: Chief Accounting Officer | link |
| 03-aug.-26 | Award | 40,973 | 86.7 | 3,551,540 | 40,973 | Walter Matthew R. | officer: SVP, Chief HR Officer | link |
| 03-aug.-26 | Award | 5,769 | - | - | 39,928 | Walter Matthew R. | officer: SVP, Chief HR Officer | link |
| 03-aug.-26 | Award | 14,421 | - | - | 14,421 | Walter Matthew R. | officer: SVP, Chief HR Officer | link |
| 03-aug.-26 | Award | 49,167 | 86.7 | 4,261,796 | 49,167 | Thompson Kweli | officer: EVP & President, Neuroscience | link |
| 03-aug.-26 | Award | 6,923 | - | - | 35,390 | Thompson Kweli | officer: EVP & President, Neuroscience | link |
| 03-aug.-26 | Award | 17,306 | - | - | 17,306 | Thompson Kweli | officer: EVP & President, Neuroscience | link |
73.3
52-week range
106.3
Your model inputs
Required return / cost of capital
%
FCFF terminal growth rate
%
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Set price notification
Valuation
Free Cash Flow Yield
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more
5.2 %
Dividend Yield TTM
3.1 %
Market cap $
$ 117,931
Price / Earnings TTM
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more
22.7
Price / Book TTM
2.3
PEG TTM
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more
6.8
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
(0.7) %
(18.9) %
33.1 %
Free cash flow per share growth
121.2 %
16.8 %
44 %
Earnings per share growth
40.7 %
40.2 %
50.4 %
Dividends
Previous dividend:0.72 per share, Paid, Ex-div date Jun 26, 2026
Next dividend:0.72 per share, Declared, Ex-div date Sep 25, 2026
Financials
all figures in USD Millions except per share data
Periods:
View:
Forecast:
Averages
based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.
Analysts
Average Revenue and Net Income forecast estimates from analysts who cover the stock.
Custom
you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.
ㅤ
Actual
10 year gagr
Estimated
Projected
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
2027
2028
2029
2030
2031
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
02FCF per share
2.9
4
2.6
4.3
4.5
3.6
4.4
3.4
3.9
4
4.2
3.7%
4.5
4.6
4.7
4.8
4.9
5
04Dividends payout, %
60.5%
59%
80.4%
58.2%
60.4%
86.5%
67.1%
96.2%
99.7%
77%
75.8%
2.3%
-
-
-
-
-
-
05Revenue
$ 28,833
$ 29,710
$ 29,953
$ 30,557
$ 28,913
$ 30,117
$ 31,686
$ 31,227
$ 32,364
$ 33,537
$ 36,364
2.4%
$ 37,218
$ 38,092
$ 38,986
$ 39,901
$ 40,838
$ 42,063
06ㅤ% Change
-
3%
0.8%
2%
(5.4)%
4.2%
5.2%
(1.5)%
3.6%
3.6%
8.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
07Net Income
3,538
4,028
3,104
4,631
4,789
3,606
5,039
3,758
3,676
4,662
4,800
3.1%
4,949
5,066
5,184
5,306
5,431
5,594
08ㅤ% Margin
12.3%
13.6%
10.4%
15.2%
16.6%
12%
15.9%
12%
11.4%
13.9%
13.2%
13.3% A
13.3%
13.3%
13.3%
13.3%
13.3%
13.3%
09CFO
5,218
6,880
4,684
7,007
7,234
6,240
7,346
6,039
6,787
7,044
7,330
3.5%
7,789
7,972
8,159
8,351
8,547
8,803
10ㅤ% Of revenue
18.1%
23.2%
15.6%
22.9%
25%
20.7%
23.2%
19.3%
21%
21%
20.2%
20.9% A
20.9%
20.9%
20.9%
20.9%
20.9%
20.9%
11CAPEX
(1,046)
(1,254)
(1,068)
(1,134)
(1,213)
(1,355)
(1,368)
(1,459)
(1,587)
(1,859)
(1,904)
6.2%
(2,022)
(2,146)
(2,279)
(2,420)
(2,569)
(2,727)
12ㅤ% Change
-
19.9%
(14.8)%
6.2%
7%
11.7%
1%
6.7%
8.8%
17.1%
2.4%
6.2% A
6.2%
6.2%
6.2%
6.2%
6.2%
6.2%
13FCFF
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
4,172
5,626
3,616
5,873
6,021
4,885
5,978
4,580
5,200
5,185
5,426
2.7%
5,768
5,826
5,881
5,931
5,978
6,076
14Total assets
99,547
99,816
91,393
89,694
90,689
93,083
90,981
90,948
89,981
91,680
93,028
(0.7)%
92,400
91,776
91,157
90,542
89,930
89,323
15ㅤ% Change
-
0.3%
(8.4)%
(1.9)%
1.1%
2.6%
(2.3)%
(0)%
(1.1)%
1.9%
1.5%
(0.7)%
(0.7)%
(0.7)%
(0.7)%
(0.7)%
(0.7)%
(0.7)%
16Total liabilities
47,719
49,400
40,571
39,482
39,817
41,481
38,259
39,283
39,561
43,424
42,956
(1.1)%
42,666
42,378
42,092
41,808
41,526
41,245
17ㅤ% Of assets
47.9%
49.5%
44.4%
44%
43.9%
44.6%
42.1%
43.2%
44%
47.4%
46.2%
46.2% A
46.2%
46.2%
46.2%
46.2%
46.2%
46.2%
18Shareholders Equity
51,828
50,416
50,822
50,212
50,872
51,602
52,722
51,665
50,420
48,256
50,072
(0.3)%
49,734
49,398
49,065
48,734
48,405
48,078
19Net Debt
28,137
28,434
22,094
20,922
20,657
22,796
20,400
22,821
23,740
26,298
26,012
(0.8)%
-
-
-
-
-
-
20Shares Outstanding
Diluted Weighted-average Shares OutstandingLearn more
1,425,900
1,391,400
1,368,200
1,357,500
1,351,100
1,354,000
1,351,400
1,332,800
1,330,200
1,289,900
1,288,100
(1)%
1,275,075
1,262,181
1,249,418
1,236,784
1,224,277
1,211,898
21ㅤ% Change
-
(2.4)%
(1.7)%
(0.8)%
(0.5)%
0.2%
(0.2)%
(1.4)%
(0.2)%
(3)%
(0.1)%
(1)%
(1)%
(1)%
(1)%
(1)%
(1)%
(1)%
22ROA
3.6%
4%
3.4%
5.2%
5.3%
3.9%
5.5%
4.1%
4.1%
5.1%
5.2%
-
5.4%
5.5%
5.7%
5.9%
6%
6.3%
23ROE
6.8%
8%
6.1%
9.2%
9.4%
7%
9.6%
7.3%
7.3%
9.7%
9.6%
-
10%
10.3%
10.6%
10.9%
11.2%
11.6%
24Interest coverage
3.9
4.9
5.8
4.3
4.4
4.8
10.4
8.6
7.2
8.2
9
-
-
-
-
-
-
-
25Dividend Yield
1.9%
2.1%
2.3%
2.3%
2.2%
1.8%
2.4%
3%
3.5%
3.3%
3.4%
-
-
-
-
-
-
-
26P/E Ratio
31.5
28.5
35.5
25.4
27.8
48.9
27.8
32.1
28.8
23.2
22.2
-
-
-
-
-
-
-
27Stock price range
65-80
71-89
77-89
80-99
73-121
89-132
100-135
76-106
69-91
77-94
81-105
-
-
-
-
-
-
-
28Market Cap
End of Period Market CapLearn more
111,570
115,469
108,712
119,574
130,893
176,074
140,093
120,586
106,535
108,968
129,308
1.5%
50,731
58,345
66,719
75,932
86,065
-
29FCF Yield
3.7%
4.9%
3.3%
5%
4.5%
2.8%
4.3%
3.8%
4.9%
4.8%
5.1%
3.1%
11.4%
10%
8.8%
7.8%
7%
-
30Average stock price
72.2
79.8
82.9
89.5
97.1
110.1
117.4
91.2
80.1
85.7
93
2.6%
39.8
46.2
53.4
61.4
70.3
-
31 CEO
GM
Geoffrey Straub Martha